PDS Biotechnology PDSB
NASDAQ PDSB
$0.71 -0.04 (-5.94%)
At close: Oct 1, 2026 · 4:00 PM EDT

PDS Biotechnology (PDSB) Cash from Financing Activities (2014 - 2025)

Updated

PDS Biotechnology's Cash from Financing Activities was $4.22 million in Q4 2025, compared with $172,778 a year earlier.

Analysis

PDS Biotechnology (PDSB) Cash from Financing Activities (2014 - 2025) Analysis & Trends

For FY2025, Cash from Financing Activities at PDS Biotechnology came in at $12.77 million, down 36.7% from FY2024.

  • Cash from Financing Activities shows a five-year compound annual growth rate of -15.6% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $20.19 million in FY2024 (+23.3%), $16.38 million in FY2023 (-52.2%), $34.29 million in FY2022 (-29.9%) and $48.89 million in FY2021 (+63.9%).
  • Quarterly Cash from Financing Activities has moved between -$13,786 (Q2 2024) and $48.77 million (Q2 2021) over five years.
  • Compared with a year earlier, Cash from Financing Activities was higher in 1 of the last four quarters, with growth averaging 19.6%.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q2 2023 (growth of 970.1%); the worst was Q2 2022 (a decline of 100.0%).
  • Per Business Quant data, PDSB's Cash from Financing Activities in the three quarters before Q4 2025 was $241,205 (Q3 2025), $995,944 (Q2 2025) and $7.32 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 PDS Biotechnology 41.94 Mn 41.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.22 Mn
Sep 30, 2025 241,205.00
Jun 30, 2025 995,944.00
Mar 31, 2025 7.32 Mn
Dec 31, 2024 172,778.00
Sep 30, 2024 17,216.00
Jun 30, 2024 -13,786.00
Mar 31, 2024 20.01 Mn
Dec 31, 2023 10.77 Mn
Sep 30, 2023 802,326.00
Jun 30, 2023 240,006.00
Mar 31, 2023 4.57 Mn
Dec 31, 2022 9.71 Mn
Sep 30, 2022 24.55 Mn
Jun 30, 2022 22,429.00
Mar 31, 2022 7,488.00
Dec 31, 2021 13.00
Sep 30, 2021 123,509.00
Jun 30, 2021 48.77 Mn
Sep 30, 2020 17.79 Mn
API Access

PDS Biotechnology Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PDSB&period=max&api_key=YOUR_API_KEY